Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID), 71808-71809 [2015-29261]
Download as PDF
<![CDATA[
71808
Federal Register / Vol. 80, No. 221 / Tuesday, November 17, 2015 / Notices
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2015–29257 Filed 11–16–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on DSK4VPTVN1PROD with NOTICES
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 80 FR 58479–58485,
dated September 29, 2015) is amended
to reflect the reorganization of the
National Center for Immunization and
Respiratory Diseases, and the Office of
Infectious Diseases, Centers for Disease
Control and Prevention.
Section C–B, Organization and
Functions, is hereby amended as
follows:
Delete in its entirety the title and
function statements for the Influenza
Coordination Unit (CVA4).
Delete in its entirety the title and
function statements for the National
Center for Immunization and
Respiratory Diseases (CVG) and insert
the following:
National Center for Immunization
and Respiratory Diseases (CVG). The
National Center for Immunization and
Respiratory Diseases (NCIRD) prevents
disease, disability, and death through
immunization and by control of
respiratory and related diseases. In
carrying out its mission, NCIRD: (1)
Provides leadership, expertise, and
service in laboratory and
epidemiological sciences, and in
immunization program delivery; (2)
conducts applied research on disease
prevention and control; (3) translates
research findings into public health
policies and practices; (4) provides
diagnostic and reference laboratory
services to relevant partners; (5)
conducts surveillance and research to
determine disease distribution,
determinants, and burden nationally
and internationally; (6) responds to
disease outbreaks domestically and
abroad; (7) ensures that public health
VerDate Sep<11>2014
18:14 Nov 16, 2015
Jkt 238001
decisions are made objectively and
based upon the highest quality of
scientific data; (8) provides technical
expertise, education, and training to
domestic and international partners; (9)
provides leadership to internal and
external partners for establishing and
maintaining immunization, and other
prevention and control programs; (10)
develops, implements, and evaluates
domestic and international public
health policies; (11) communicates
information to increase awareness,
knowledge, and understanding of public
health issues domestically and
internationally, and to promote effective
immunization programs; (12) aligns the
national center focus with the overall
strategic goals of CDC; (13) synchronizes
all aspects of CDC’s pandemic influenza
preparedness and response from
strategy through implementation and
evaluation; and (14) implements,
coordinates, and evaluates programs
across NCIRD, Office of Infectious
Diseases (OID), and CDC to optimize
public health impact.
Delete in its entirety the title and
function statements for the Office of
Laboratory Science (CVG14).
After the Office of Science and
Integrated Programs (CVG17) insert the
following:
Influenza Coordination Unit (CVG18).
The mission of the Influenza
Coordination Unit (ICU) is to
synchronize all aspects of CDC’s
pandemic influenza preparedness and
response from strategy through
implementation and evaluation. In
carrying out its mission, the ICU: (1)
Serves as the principal advisor to the
CDC Director on pandemic influenza
preparedness and response activities,
assisting the Director in formulating and
communicating strategic pandemic
initiatives and policies; (2) provides
strategic leadership for CDC in the areas
of pandemic preparedness and
response, including setting priorities
and promoting science, policies, and
programs related to pandemic influenza;
(3) strategically manages a budget and
allocates funds across the agency to
ensure appropriate resources for high
priority areas; and (4) conducts ongoing
evaluation and adjustment of pandemic
preparedness and response activities, in
coordination with the National
Response Framework and other
emergency preparedness guidance, to
ensure optimal public health
effectiveness and efficient use of human
and fiscal resources by developing and
leading an exercise program for the
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
Agency, in collaboration with HHS and
other partners.
James Seligman,
Acting Chief Operating Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2015–29282 Filed 11–16–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors, Office
of Infectious Diseases (BSC, OID)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Time and Date:
8:30 a.m.–5:00 p.m., EST, December 9, 2015
8:00 a.m.–12:00 p.m., EST, December 10,
2015
Place: CDC, Global Communications Center,
1600 Clifton Road, NE., Building 19,
Auditorium B3, Atlanta, Georgia 30333.
Status: The meeting is open to the public,
limited only by the space available.
Purpose: The BSC, OID, provides advice
and guidance to the Secretary, Department of
Health and Human Services; the Director,
CDC; the Director, OID; and the Directors of
the National Center for Immunization and
Respiratory Diseases, the National Center for
Emerging and Zoonotic Infectious Diseases,
and the National Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention, CDC, in
the following areas: Strategies, goals, and
priorities for programs; research within the
national centers; and overall strategic
direction and focus of OID and the national
centers.
Matters for Discussion: The meeting will
include reports from the Board’s Food Safety
Modernization Act Surveillance Working
Group and Infectious Disease Laboratory
Working Group; brief updates on selected
activities of CDC’s infectious disease national
centers; and updates and focused discussions
on prevention of Legionella disease and
efforts to better understand and address
environmental factors contributing to
infectious disease outbreaks.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Robin Moseley, M.A.T., Designated Federal
Officer, OID, CDC, 1600 Clifton Road NE.,
Mailstop D10, Atlanta, Georgia 30333,
Telephone: (404) 639–4461.
The Director, Management Analysis and
Services Office has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
E:\FR\FM\17NON1.SGM
17NON1
Federal Register / Vol. 80, No. 221 / Tuesday, November 17, 2015 / Notices
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2015–29261 Filed 11–16–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
agreement awardees and to identify
challenges to program implementation
and achievement of outcomes. This
proposed data collection also received
publication for public comment on
November 9, 2015 under Docket ID
60Day–16–16BZ; Docket No. CDC–
2015–0095.
FOR FURTHER INFORMATION CONTACT:
(404) 639–7570 or send comments to
CDC, Leroy Richardson, 1600 Clifton
Road, MS D–74, Atlanta, GA 30333 or
send an email to omb@cdc.gov.
Dated: November 12, 2015.
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[60Day–16–16BX; Docket No. CDC–2016–
0092]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
[FR Doc. 2015–29297 Filed 11–12–15; 4:15 pm]
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Cancellation of notice with
comment period.
BILLING CODE P
The notice ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’ on
Monitoring and Reporting for the Core
State Violence and Injury Prevention
Program Cooperative Agreement (80 FR
68543, November 5, 2015) is cancelled.
This notice invited comment on a
proposed information collection entitled
‘‘Monitoring and Reporting for the Core
State Violence and Injury Prevention
Program Cooperative Agreement,’’
where CDC would use the information
collected to monitor cooperative
Administration for Children and
Families
AGENCY:
SUMMARY:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Submission for OMB Review;
Comment Request
Title: Permanency Innovations
Initiative Evaluation: Phase 4
OMB No.: 0970–0408
Description: The Administration for
Children and Families (ACF), U.S.
Department of Health and Human
Services (HHS) intends to collect
additional data for an evaluation of the
Permanency Innovations Initiative (PII).
71809
This 5-year initiative, funded by the
Children’s Bureau (CB) within ACF, is
intended to build the evidence base for
innovative interventions that enhance
well-being and improve permanency
outcomes for particular groups of
children and youth who are at risk for
long-term foster care and who
experience the most serious barriers to
timely permanency.
Data collection for the PII evaluation
includes a number of components
beginning at different points in time.
Phase 1 (approved August 2012, OMB#
0970–0408) included data collection for
a cross-site implementation evaluation
and site-specific evaluations of two PII
grantees (Washoe County, Nevada, and
the State of Kansas). Phase 2 (approved
August 2013) included data collection
for two more PII grantees (Illinois DCFS
and one of two interventions offered by
the Los Angeles LGBTQ Center’s
Recognize Intervene Support Empower
[RISE] project). Phase 3 (approved July
2014) included data collection for an
evaluation of another PII grantee
intervention and two additional crosssite PII studies. The grantee intervention
was a second RISE intervention, the
Care Coordination Team (CCT). The two
PII cross-site studies were a cost study
and an administrative data study.
The current request if for Phase 4 and
includes data collection for another PII
grantee, the California Department of
Social Services’ California Partnership
for Permanency (CAPP) project.
Respondents: Spanish and English
speaking biological parents, legal
guardians, foster parents (or caregivers)
ANNUAL BURDEN ESTIMATES
Total number
of respondents
Annual
number of
respondents
Number of
responses per
respondent
Average
burden
hours per
response
CAPP Parent-Legal Guardian Questionnaire ....................
CAPP Caregiver Questionnaire .........................................
CAPP annual burden hours ........................................
mstockstill on DSK4VPTVN1PROD with NOTICES
Instrument
1673
1763
..........................
558
587
........................
1
1
........................
.6
.6
........................
Additional Information: Copies of the
proposed collection may be obtained by
writing to the Administration for
Children and Families, Office of
Planning, Research and Evaluation, 370
L’Enfant Promenade SW., Washington,
DC 20447, Attn: OPRE Reports
Clearance Officer. All requests should
be identified by the title of the
information collection. Email address:
OPREinfocollection@acf.hhs.gov.
OMB COMMENT: OMB is required to
make a decision concerning the
collection of information between 30
and 60 days after publication of this
VerDate Sep<11>2014
18:14 Nov 16, 2015
Jkt 238001
document in the Federal Register.
Therefore, a comment is best assured of
having its full effect if OMB receives it
within 30 days of publication. Written
comments and recommendations for the
proposed information collection should
be sent directly to the following: Office
of Management and Budget, Paperwork
Reduction Project, Email: OIRA_
SUBMISSION@OMB.EOP.GOV, Attn:
PO 00000
Frm 00040
Fmt 4703
Sfmt 9990
Total
annual
burden
hours
335
352
687
Desk Officer for the Administration for
Children and Families.
Robert Sargis,
ACF Reports Clearance Officer.
[FR Doc. 2015–29338 Filed 11–16–15; 8:45 am]
BILLING CODE 4184–01–P
E:\FR\FM\17NON1.SGM
17NON1
]]>Agencies
[Federal Register Volume 80, Number 221 (Tuesday, November 17, 2015)]
[Notices]
[Pages 71808-71809]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-29261]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, Office of Infectious Diseases
(BSC, OID)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting of the aforementioned
committee:
Time and Date:
8:30 a.m.-5:00 p.m., EST, December 9, 2015
8:00 a.m.-12:00 p.m., EST, December 10, 2015
Place: CDC, Global Communications Center, 1600 Clifton Road, NE.,
Building 19, Auditorium B3, Atlanta, Georgia 30333.
Status: The meeting is open to the public, limited only by the
space available.
Purpose: The BSC, OID, provides advice and guidance to the
Secretary, Department of Health and Human Services; the Director,
CDC; the Director, OID; and the Directors of the National Center for
Immunization and Respiratory Diseases, the National Center for
Emerging and Zoonotic Infectious Diseases, and the National Center
for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, in the
following areas: Strategies, goals, and priorities for programs;
research within the national centers; and overall strategic
direction and focus of OID and the national centers.
Matters for Discussion: The meeting will include reports from
the Board's Food Safety Modernization Act Surveillance Working Group
and Infectious Disease Laboratory Working Group; brief updates on
selected activities of CDC's infectious disease national centers;
and updates and focused discussions on prevention of Legionella
disease and efforts to better understand and address environmental
factors contributing to infectious disease outbreaks.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Robin Moseley, M.A.T.,
Designated Federal Officer, OID, CDC, 1600 Clifton Road NE.,
Mailstop D10, Atlanta, Georgia 30333, Telephone: (404) 639-4461.
The Director, Management Analysis and Services Office has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and
[[Page 71809]]
Prevention and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2015-29261 Filed 11-16-15; 8:45 am]
BILLING CODE 4163-18-P
